AMGEN DEAL: Biotech pioneer Amgen will pay $415 million for Iceland's deCODE Genetics, a leader in using genetic information to find disease risk factors and treatment targets.
THE RATIONALE: Amgen, the world's largest biotech company by revenue, wants to use deCODE's huge database of genetic and medical information on Iceland's population to find targets for diseases linked to genes.
THE NEED: Drug and biotech companies spend hundreds of millions of dollars on testing experimental drugs, most of which ultimately don't work out. They're all trying to find ways to identify the winners and weed out the losers much sooner.
Judicial Watch: Hillary e-mail requested printout “without any identifiers”
After Youtube Terminated His Account Twice, Hickok45 Found A New Home
Toxic Words | Human Events
Report: Hillary's Wall Street Speech Transcripts Would 'Bury Her'
Mike Shedlock - European Bloodbath Spills Over to US Markets: Deutsche Bank CoCo Bonds Collapse, Shares at Record Low
'Watch out for those scary opinions'! Twitter introduces glorified speech police
FAIL. Marco Rubio Foils Attempted Troll By Alleged Homosexual | RedState